Many of the patients ended up dying. Others had much longer than 5 day courses (at least 7-10) and off the top of my head I don't remember one patient having a course that improved significantly quickly that we thought it was bc of the drug.

That said, there are a lot of variables that are not accounted. Gilead picked their patients for this. How about we randomize?

It could blow up or it could turn into nothing. But I believe it was leaked to pump the market. Which it's doing z great job of lol.

Separate from all that - they can't make the drug fast enough. They're reporting only a million doses by end of year max. I guess that's enough for America maybe? IDK. I've learned my lessons about locking in profits.

Next time I have profits I'll lock em and be happy with em. Or at least lock half.